4//SEC Filing
ONYX PHARMACEUTICALS INC 4
Accession 0001179110-13-011357
CIK 0001012140operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:54 PM ET
Size
8.0 KB
Accession
0001179110-13-011357
Insider Transaction Report
Form 4
Lasowski Juergen
SVP, Corporate Development
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2013-07-01−25,375→ 2,625 totalExercise: $28.55Exp: 2019-03-31→ Common Stock (25,375 underlying) - Exercise/Conversion
Common Stock
2013-07-01$28.55/sh+25,375$724,456→ 57,458 total - Sale
Common Stock
2013-07-01$132.63/sh−25,375$3,365,486→ 32,083 total
Footnotes (2)
- [F1]Shares sold pursuant to 10b5-1 plan.
- [F2]Fully vested.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001012140
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 6:54 PM ET
- Size
- 8.0 KB